[PDF] Top 20 Lithium in the Acute Treatment of Bipolar I Disorder: A Double-Blind, Placebo-Controlled Study
Has 10000 "Lithium in the Acute Treatment of Bipolar I Disorder: A Double-Blind, Placebo-Controlled Study" found on our website. Below are the top 20 most common "Lithium in the Acute Treatment of Bipolar I Disorder: A Double-Blind, Placebo-Controlled Study".
Lithium in the Acute Treatment of Bipolar I Disorder: A Double-Blind, Placebo-Controlled Study
... serum lithium level ...receive placebo were preassigned to a maximum dose at randomization to maintain the integrity of the ...to study medication was monitored by using a dosing diary and pill ... See full document
12
Aripiprazole in the acute and maintenance phase of bipolar I disorder
... with placebo when used as an adjuvant therapy to lithium and valproate during a 6-week double-blind placebo-controlled study involving 384 manic or mixed ...of ... See full document
6
A RANDOMIZED DOUBLE BLIND PLACEBO CONTROLLED STUDY OF ASHWAGANDHA ON GENERALIZED ANXIETY DISORDER .......
... Generalized Anxiety Disorder (GAD) is the most frequent anxiety disorder which comes across in the primary care settings. It is associated with considerable economic costs owing to its low work productivity ... See full document
7
Aripiprazole for the maintenance treatment of bipolar disorder: a review of available evidence
... continued double-blind treatment to week 12 at which time they could enter a 40-week double-blind extension ...aripiprazole, lithium or placebo respectively completed the ... See full document
5
Maintenance N-acetyl cysteine treatment for bipolar disorder: A double-blind randomized placebo controlled trial
... [16], Bipolar Depression Rating Scale (BDRS) [17], Young Mania Rating Scale (YMRS) [18], Clinical Global Impression (CGI) improvement and sever- ity scales [19], CGI modified for substance use [20] ... See full document
11
The Efficacy of Probiotics for Treatment of Bipolar Disorder- Type 1: A Randomized, Double-Blind, Placebo-Controlled Trial
... including bipolar disorders (20, ...in bipolar patients than in the nonbipolar (9). Study of Pinto-Sanchez et al in 2017 showed that consumption of probiotic Bifidobacterium longum both reduces ... See full document
7
Patterns of response to aripiprazole, lithium, haloperidol, and placebo across factor scores of mania
... of treatment strategies for mania is the need for early clinical prediction of re- sponse to a particular ...to lithium or ziprasidone predicted treatment outcome in acute manic and mixed ... See full document
9
Efficacy of ketamine in the rapid treatment of major depressive disorder: a meta-analysis of randomized, double-blind, placebo-controlled studies
... the acute treatment of patients with ...our study also indicated that ketamine might be a good choice in the acute treatment phase for TRD ... See full document
9
Lithium for prevention of mood episodes in bipolar disorders: systematic review and meta-analysis
... with bipolar disorders. Lithium proved superior to anticonvulsants in the prevention of manic episodes, while there was no significant difference regarding the prevention of depressive episodes, overall ... See full document
17
A randomized, double blind, placebo controlled trial to assess the efficacy of topiramate in the treatment of post traumatic stress disorder
... Axis I and Axis II (SCID-I and SCID-II, respectively) by a trained psychiatrist ...the study. The exclusion criteria will be: 1) lifetime history of bipolar, psychotic, borderline per- ... See full document
7
Spotlight on once-monthly long-acting injectable aripiprazole and its potential as maintenance treatment for bipolar I disorder in adult patients
... the treatment of bipolar disorder, particularly during the maintenance phase when symptoms are less ...of bipolar disorder and can add hundreds of thousands of dollars to the lifetime ... See full document
8
Diuretic versus placebo in normotensive acute pulmonary embolism with right ventricular enlargement and injury: a double-blind randomised placebo controlled study. Protocol of the DiPER study
... symptomatic treatment, the challenge is to overcome RV ...during acute PE, and results from increased wall stress and cardiac ischae- mia, both related to pressure ...in acute PE improves cardiac ... See full document
6
Revisiting loxapine: a systematic review
... the treatment of bipolar mania [35]. One small placebo-controlled study supports the efficacy of chlorpromazine [36] while several studies support the efficacy of haloperidol in this ... See full document
8
Patient perspectives on use of long-acting antipsychotics in bipolar disorder: focus on risperidone injection
... recent acute manic or mixed episode (with YMRS score $20), or the need for euthymic patients (CGI-S score #3) to change treatment for safety ...the study were ...a placebo group and an RLAI ... See full document
10
Profile of vortioxetine in the treatment of major depressive disorder: an overview of the primary and secondary literature
... with placebo (positive treatment response, OR ...of study outcome. No single study appeared to have too great an impact on the results from the overall analysis, as was the case with the first ... See full document
20
Overview of the pathogenesis and treatment of chronic inflammatory demyelinating polyneuropathy with intravenous immunoglobulins
... geneous disorder of immune origin affecting the peripheral nerves, causing motor weakness and sensory symptoms and ...effective treatment for ...its treatment with ... See full document
5
Pharmacology and clinical potential of vortioxetine in the treatment of major depressive disorder
... versus placebo. When active comparators were included in the study design, no significant differ- ences were found except in one study in which the efficacy of vortioxetine was superior to the ... See full document
11
Probiotics: Not Just for Treatment Anymore
... a placebo for- ...the placebo group. For example, the subjects in the placebo, B lactis, and L reuteri groups averaged ...12-week study pe- riod), ... See full document
6
Evidence-based guideline: Treatment of tardive syndromesReport of the Guideline Development Subcommittee of the American Academy of Neurology
... TDS treatment? Limited evidence is avail- able to determine the long-term effect of antipsy- chotic withdrawal on ...Different study designs and heterogeneous study populations examining DRBA ... See full document
9
Update on optimal use of lisdexamfetamine in the treatment of ADHD
... the placebo group, ADHD Rating Scale Version IV (ADHD-RS-IV) score reductions were 4–5-fold (P , ...of treatment, and included decreased appetite, weight loss, insomnia, upper abdominal pain, headache, ... See full document
7
Related subjects